New Chance for Better Pandemic Response

Researchers at TU Braunschweig and HZI succeed in developing neutralizing anti-SARS-CoV-2 antibodies from immune cells of healthy donors

An international research team of the Technische Universität Braunschweig and the Helmholtz Centre for Infection Research (HZI), led by the Department of Biotechnology of the TU Braunschweig, has reported on the development of special antibodies against SARS-CoV-2 in the journal Nature Communications. These antibodies prevent the viruses from entering host cells and were isolated from an antibody gene library that had already been produced from immune cells of healthy donors before the pandemic. The study shows how, in the future, active substances to previously unknown, emerging viruses can be produced very quickly without patient material.

Involved BRICS research group: Prof. Dr. Stefan Dünbel

HZI News